Phase 3 in May for 3rd RNA vax. Stable at fridge temp. No deep freezers needed: “CureVac’s RNA vaccine can stay stable for at least three months at 41 degrees F (fridge), and it can sit for 24 hours at room temperature before it is used.” via @NYTimes https://t.co/RMEUstoDAf
— Mark Zelman (@MarkZelman) May 5, 2021
EMA has started a rolling review of CVnCoV, a #COVID19vaccine developed by CureVac AG:
— EU Medicines Agency (@EMA_News) February 12, 2021
https://t.co/risZxVYHuS pic.twitter.com/n0nofi1hcU
Kjurvak pritom koristi 8x manje RNK materijala od Moderne, odnosno 2,5x manje od Bionteka, što bi trebalo da znači da će obim proizvodnje moći brže da se poveća.
https://www1.racgp.org.au/newsgp/clinical/four-things-about-mrna-covid-vaccines-researchersThe current mRNA vaccine doses range from 30 micrograms (Pfizer/BioNTech) to 100 micrograms (Moderna). In phase 1 clinical trials, lower doses of the Pfizer/BioNTech vaccine were also active.
Could we go lower than this? CureVac has developed a COVID-19 mRNA vaccine with a dose of 12 micrograms through a combination of innovations in mRNA sequence and lipid formulations. However, the details of this remain proprietary.